| Jeanie D Dassow, MD | |
|
979 East Third Street, Suite C-725, Chattanooga, TN 37403-3329 | |
| (423) 778-2580 | |
| (423) 778-7489 |
| Full Name | Jeanie D Dassow |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 37 Years |
| Location | 979 East Third Street, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740226562 | NPI | - | NPPES |
| 64002900 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 35445 (Kentucky) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 46420 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Erlanger Medical Center | Chattanooga, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Erlanger Health | 1153780226 | 352 |
News Archive
The nature-nurture debate is usually about how much of something is due to our genes and how much is caused by our environment. New research just published in the academic journal Addiction shows that the case is more interesting for young women who smoke, drink, or use drugs, for two related reasons.
Genentech, a member of the Roche Group, today announced results from OCEANS, a Phase III study evaluating Avastin (bevacizumab) in combination with chemotherapy followed by the continued use of Avastin alone in women with previously treated (recurrent) platinum-sensitive ovarian cancer.
Ranbaxy Laboratories Limited has announced that a Norwegian court handed down a favorable decision for Ranbaxy in its case against Pfizer, involving two patents on atorvastatin in Norway.
Jazz Pharmaceuticals, Inc. announced that data from the company's first Phase III clinical trial of sodium oxybate (JZP-6) for the treatment of fibromyalgia will be presented during the American College of Rheumatology 2009 Annual Meeting (ACR) in Philadelphia, Pennsylvania and also in November during the US Psychiatric and Mental Health Congress (US Psych Congress) in Las Vegas, Nevada.
› Verified 3 days ago
| Entity Name | Chattanooga Hamilton County Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154751931 PECOS PAC ID: 0547179731 Enrollment ID: O20040302001086 |
News Archive
The nature-nurture debate is usually about how much of something is due to our genes and how much is caused by our environment. New research just published in the academic journal Addiction shows that the case is more interesting for young women who smoke, drink, or use drugs, for two related reasons.
Genentech, a member of the Roche Group, today announced results from OCEANS, a Phase III study evaluating Avastin (bevacizumab) in combination with chemotherapy followed by the continued use of Avastin alone in women with previously treated (recurrent) platinum-sensitive ovarian cancer.
Ranbaxy Laboratories Limited has announced that a Norwegian court handed down a favorable decision for Ranbaxy in its case against Pfizer, involving two patents on atorvastatin in Norway.
Jazz Pharmaceuticals, Inc. announced that data from the company's first Phase III clinical trial of sodium oxybate (JZP-6) for the treatment of fibromyalgia will be presented during the American College of Rheumatology 2009 Annual Meeting (ACR) in Philadelphia, Pennsylvania and also in November during the US Psychiatric and Mental Health Congress (US Psych Congress) in Las Vegas, Nevada.
› Verified 3 days ago
| Entity Name | Erlanger Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477256303 PECOS PAC ID: 1153780226 Enrollment ID: O20230707000849 |
News Archive
The nature-nurture debate is usually about how much of something is due to our genes and how much is caused by our environment. New research just published in the academic journal Addiction shows that the case is more interesting for young women who smoke, drink, or use drugs, for two related reasons.
Genentech, a member of the Roche Group, today announced results from OCEANS, a Phase III study evaluating Avastin (bevacizumab) in combination with chemotherapy followed by the continued use of Avastin alone in women with previously treated (recurrent) platinum-sensitive ovarian cancer.
Ranbaxy Laboratories Limited has announced that a Norwegian court handed down a favorable decision for Ranbaxy in its case against Pfizer, involving two patents on atorvastatin in Norway.
Jazz Pharmaceuticals, Inc. announced that data from the company's first Phase III clinical trial of sodium oxybate (JZP-6) for the treatment of fibromyalgia will be presented during the American College of Rheumatology 2009 Annual Meeting (ACR) in Philadelphia, Pennsylvania and also in November during the US Psychiatric and Mental Health Congress (US Psych Congress) in Las Vegas, Nevada.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeanie D Dassow, MD Po Box 11589, Chattanooga, TN 37401-2589 Ph: (423) 778-3274 | Jeanie D Dassow, MD 979 East Third Street, Suite C-725, Chattanooga, TN 37403-3329 Ph: (423) 778-2580 |
News Archive
The nature-nurture debate is usually about how much of something is due to our genes and how much is caused by our environment. New research just published in the academic journal Addiction shows that the case is more interesting for young women who smoke, drink, or use drugs, for two related reasons.
Genentech, a member of the Roche Group, today announced results from OCEANS, a Phase III study evaluating Avastin (bevacizumab) in combination with chemotherapy followed by the continued use of Avastin alone in women with previously treated (recurrent) platinum-sensitive ovarian cancer.
Ranbaxy Laboratories Limited has announced that a Norwegian court handed down a favorable decision for Ranbaxy in its case against Pfizer, involving two patents on atorvastatin in Norway.
Jazz Pharmaceuticals, Inc. announced that data from the company's first Phase III clinical trial of sodium oxybate (JZP-6) for the treatment of fibromyalgia will be presented during the American College of Rheumatology 2009 Annual Meeting (ACR) in Philadelphia, Pennsylvania and also in November during the US Psychiatric and Mental Health Congress (US Psych Congress) in Las Vegas, Nevada.
› Verified 3 days ago
John Sindos Adams Sr., MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 929 Spring Creek Road, Suite 104, Chattanooga, TN 37412 Phone: 423-510-0250 Fax: 423-510-9524 | |
Dr. Alicia Renee Allen, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1651 Gunbarrel Rd Ste 201, Chattanooga, TN 37421 Phone: 423-899-9133 Fax: 423-855-8176 | |
Dr. Charles Patrick Johnson, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1751 Gunbarrel Rd, Suite 101, Chattanooga, TN 37421 Phone: 423-778-8558 Fax: 423-778-8560 | |
Dr. William Joel Moss, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1755 Gunbarrel Rd, Suite 205, Chattanooga, TN 37421 Phone: 423-756-0863 Fax: 706-937-2377 | |
Mr. Gary A. Brunvoll, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7490 Ziegler Rd, Chattanooga, TN 37421 Phone: 423-648-6020 Fax: 423-648-6025 | |
Elizabeth Maria Bowers, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1751 Gunbarrel Road, Suite 100, Chattanooga, TN 37421 Phone: 423-778-9500 Fax: 423-778-8882 | |
Porche' Warren Adams, DO, MPH Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 935 Spring Creek Rd Ste 100, Chattanooga, TN 37412 Phone: 423-510-0250 Fax: 423-510-9524 |